CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity.
Haiyang LiLingwa WangZhaohui RuanXiaoyan LiYifan YangJugao FangRu Wang
Published in: Expert review of clinical immunology (2024)
Our findings demonstrate that CSE1L promotes tumor development in various malignancies, highlighting its potential as both a therapeutic target and prognostic indicator.